AGTC files investigational NDA for X-linked retinitis pigmentosa gene therapy – Healio
AGTC files investigational NDA for X-linked retinitis pigmentosa gene therapyHealioApplied Genetic Technologies Corporation has filed an investigational new drug application with the FDA to begin a phase 1/2 clinical trial of its gene therapy candidate… Continue reading
